膀胱刺激症状を有する患者に対するFlavoxate hydrochloride錠の使用経験

Abstract

Flavoxate hydrochloride was administered to the patients with vesical neurosis and postcystitis symptoms such as intractable pollakisuria, urinary urgency, feeling of residual urine and unpleasant feeling on micturition. Effectiveness rate of the test drug for symptomatic improvement was evaluated as 55 %, whereas that of the control medicine (placebo) was 28.6 %. The test drug was significantly superior to the placebo. As to dosage of flavoxate, 600 mg per day was favorable than 300 mg per day as far as the clinical response was concerned. Combined use of sulfa drug did not affect the results. No side effect was observed at all.